SBC Medical Group (NASDAQ:SBC) Stock Bumped Down to Buy by Wall Street Zen
by Danessa Lincoln · The Markets DailyWall Street Zen cut shares of SBC Medical Group (NASDAQ:SBC – Free Report) from a strong-buy rating to a buy rating in a report published on Sunday,Wall Street Zen reports.
Several other brokerages have also recently issued reports on SBC. BTIG Research restated a “buy” rating and set a $8.00 price objective on shares of SBC Medical Group in a research note on Thursday, August 13th. Weiss Ratings raised shares of SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, September 22nd. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, SBC Medical Group currently has a consensus rating of “Moderate Buy” and an average price target of $8.50.
Read Our Latest Stock Report on SBC
SBC Medical Group Price Performance
Shares of SBC Medical Group stock opened at $4.90 on Friday. SBC Medical Group has a 1-year low of $2.78 and a 1-year high of $5.29. The company has a market capitalization of $503.97 million, a PE ratio of 10.43 and a beta of 0.63. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27. The business has a 50-day moving average of $3.84 and a 200-day moving average of $3.57.
SBC Medical Group (NASDAQ:SBC – Get Free Report) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.02). SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%.The business had revenue of $49.19 million during the quarter, compared to analyst estimates of $45.37 million. As a group, equities analysts forecast that SBC Medical Group will post 0.44 EPS for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the business. State Street Corp raised its position in shares of SBC Medical Group by 59.7% during the second quarter. State Street Corp now owns 49,239 shares of the company’s stock worth $152,000 after purchasing an additional 18,400 shares during the period. Citadel Advisors LLC bought a new position in shares of SBC Medical Group during the 2nd quarter valued at $446,000. Two Sigma Securities LLC bought a new stake in SBC Medical Group during the second quarter worth approximately $66,000. Bank of America Corp DE bought a new position in shares of SBC Medical Group in the second quarter worth about $35,000. Finally, BlackRock Inc. bought a new position in SBC Medical Group in the 2nd quarter worth approximately $2,846,000. Institutional investors and hedge funds own 60.82% of the company’s stock.
SBC Medical Group Company Profile
SBC Medical Group (NASDAQ: SBC) is a Japan-based medical services and management company focused primarily on the aesthetic medicine sector. Through its affiliated medical corporations and clinic network, the company supports the operation of facilities offering cosmetic surgery, cosmetic dermatology and related elective treatments.
The company provides a range of management and operational services to affiliated clinics, including branding and marketing, staff recruitment and training, purchasing, information technology, administrative support and business consulting.